Reprieve Cardiovascular

Reprieve Cardiovascular is a healthcare company in Milford, United States, founded in 2018. It has raised $103.0M across 2 rounds, most recently a $61.0M Series B in August 2025.

Bringing intelligence to decongestion management for heart failure patients

Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$103.0M
Last Round
$61.0M Series BAug 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.

About

Reprieve Cardiovascular is a pioneering medical device company focused on automated fluid management technologies for patients with acute decompensated heart failure (ADHF). The company's Reprieve System combines real-time diuretic response measurement, semi-automated IV diuretic titration, and precise fluid removal monitoring to give physicians full visibility and control throughout decongestion therapy. By replacing the 60-year-old standard-of-care diuretic approach with an intelligent, data-driven alternative, Reprieve aims to safely accelerate fluid removal, reduce average hospital stays, and improve outcomes for the 8.5 million heart failure patients hospitalized annually in the United States.

Summary

It lists 11–50 employees. It has raised $103.0M in total across 2 rounds, most recently a $61.0M Series B round in Aug 2025. Investors include Deerfield Management, Lightstone Ventures and Sante Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BAug 2025
$61.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Neko Health

Neko Health delivers preventive health scans that combine skin, heart, blood, and body measuremen...

Stockholm, Sweden201–500Artificial Intelligence, Digital Health
Series CTotal funding$1.1BJul 2026
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Reprieve Cardiovascular on Indexed.vc
<a href="https://indexed.vc/companies/reprieve-cardiovascular"><img src="https://indexed.vc/api/badge/company/reprieve-cardiovascular" alt="Reprieve Cardiovascular on Indexed.vc" width="260" height="76" /></a>